William A. Schumacher

2.8k citations

82 papers · 2.0k indexed · h-index 27

Hematology top 1%
Genetics top 1%
Cardiology and Cardiovascular Medicine top 5%
Molecular Biology
Immunology top 10%

Co-authors: Martin L. Ogletree Patricia L. Smith Thomas E. Steinbacher Dietmar Seiffert Benedict R. Lucchesi Christopher L. Heran M‐Y. HSU David Gailani
Topics: Blood Coagulation and Thrombosis Mechanisms (24 papers)Coagulation, Bradykinin, Polyphosphates, and Angioedema (21 papers)Antiplatelet Therapy and Cardiovascular Diseases (18 papers)
Cited by: Hematology Internal Medicine Genetics
Journals: Circulation Blood Journal of the American College of Cardiology
Partner nations: United States Germany Sweden

In The Last Decade

William A. Schumacher

80 papers receiving 1.9k citations

Peers

Countries citing papers authored by William A. Schumacher

Since Specialization

Citations

This map shows the geographic impact of William A. Schumacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William A. Schumacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William A. Schumacher more than expected).

Fields of papers citing papers by William A. Schumacher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William A. Schumacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William A. Schumacher. The network helps show where William A. Schumacher may publish in the future.

Co-authorship network of co-authors of William A. Schumacher

This figure shows the co-authorship network connecting the top 25 collaborators of William A. Schumacher. A scholar is included among the top collaborators of William A. Schumacher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William A. Schumacher. William A. Schumacher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification of a Hydroxypyrimidinone Compound (21) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure 2021 ·Journal of Medicinal Chemistry ·Wei Meng,Zulan Pi,(unknown),Karen A. Rossi,William A. Schumacher,Jeffrey S. Bostwick,Peter S. Gargalovic,Joelle M. Onorato,(unknown),(unknown),Tao Wang,Ruth R. Wexler,Heather J. Finlay	7
2	Discovery of nonbenzamidine factor VIIa inhibitors using a biaryl acid scaffold 2013 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),James Sutton,(unknown),Gregory S. Bisacchi,Bruce L. Jacobson,William A. Slusarchyk,(unknown),Shung Wu,Guohua Zhao,Zulan Pi,S. Sheriff,(unknown),(unknown),Daniel L. Cheney,Anzhi Wei,William A. Schumacher,Karen S. Hartl,(unknown),Robert Zahler,Steven M. Seiler	12
3	A small-molecule factor XIa inhibitor produces antithrombotic efficacy with minimal bleeding time prolongation in rabbits 2011 ·Journal of Thrombosis and Thrombolysis ·Pancras C. Wong,Earl J. Crain,Carol A. Watson,William A. Schumacher	61
4	Cyanoguanidine-based lactam derivatives as a novel class of orally bioavailable factor Xa inhibitors 2009 ·Bioorganic & Medicinal Chemistry Letters ·Yan Shi,Jing Zhang,Mengxiao Shi,Stephen P. O’Connor,(unknown),Chi Li,Doree Sitkoff,Andrew T. Pudzianowski,Saeho Chong,Herbert E. Klei,Kevin Kish,Joseph Yanchunas,Eddie C.‐K. Liu,Karen S. Hartl,(unknown),Thomas E. Steinbacher,William A. Schumacher,Karnail S. Atwal,Philip D. Stein	13
5	Biomarker Optimization to Track the Antithrombotic and Hemostatic Effects of Clopidogrel in Rats 2007 ·Journal of Pharmacology and Experimental Therapeutics ·William A. Schumacher,Jeffrey S. Bostwick,Martin L. Ogletree,(unknown),Thomas E. Steinbacher,Ji Hua,Laura A. Price,Pancras C. Wong,Robert Rehfuss	29
6	Abstract 631: Nonpeptide Factor XIa (FXIa) Inhibitor. In vitro Kinetic Evaluation and in vivo Studies of BMS-262084 on Arterial Thrombosis and Hemostasis in Rabbits 2006 ·Circulation ·Pancras C. Wong,William A. Schumacher,Carol A. Watson,Earl J. Crain,Martin L. Ogletree,Alan R. Rendina	3
7	Quantification of platelet composition in experimental venous thrombosis by real-time polymerase chain reaction 2006 ·Thrombosis Research ·Xinkang Wang,Mei-Yin Hsu,Thomas E. Steinbacher,Thomas M. Monticello,William A. Schumacher	26
8	Effects of factor XI deficiency on ferric chloride‐induced vena cava thrombosis in mice 2006 ·Journal of Thrombosis and Haemostasis ·Xianyu Wang,Patricia L. Smith,M‐Y. HSU,David Gailani,William A. Schumacher,Martin L. Ogletree,Dietmar Seiffert	112
9	Murine model of ferric chloride‐induced vena cava thrombosis: evidence for effect of potato carboxypeptidase inhibitor 2006 ·Journal of Thrombosis and Haemostasis ·(unknown),Patricia L. Smith,Mei-Yin Hsu,Martin L. Ogletree,William A. Schumacher	77
10	Effects of factor IX or factor XI deficiency on ferric chloride‐induced carotid artery occlusion in mice 2005 ·Journal of Thrombosis and Haemostasis ·Xianyu Wang,Qi Cheng,(unknown),G Feuerstein,M‐Y. HSU,Patricia L. Smith,Dietmar Seiffert,William A. Schumacher,Martin L. Ogletree,David Gailani	233
11	Inhibition of Tumor Necrosis Factor-α-Converting Enzyme by a Selective Antagonist Protects Brain from Focal Ischemic Injury in Rats 2004 ·Molecular Pharmacology ·Xinkang Wang,Giora Feuerstein,Lin Xu,Hugh Wang,William A. Schumacher,Martin L. Ogletree,Rebecca Taub,James J.‐W. Duan,Carl P. Decicco,Rui‐Qin Liu	70
12	Synthesis of potent and highly selective inhibitors of human tryptase 2002 ·Bioorganic & Medicinal Chemistry Letters ·William A. Slusarchyk,(unknown),Karen S. Hartl,Ming‐Hsing Huang,G. A. JACOBS,Wei Meng,Martin L. Ogletree,Zulan Pi,William A. Schumacher,Steven M. Seiler,James Sutton,(unknown),Robert Zahler,Guohua Zhao,Gregory S. Bisacchi	41
13	Molecular design and structure–Activity relationships leading to the potent, selective, and orally active thrombin active site inhibitor BMS-189664 2002 ·Bioorganic & Medicinal Chemistry Letters ·Jagabandhu Das,S. David Kimball,Steven E. Hall,(unknown),Edwin J. Iwanowicz,James C. Lin,Robert V. Moquin,(unknown),John S. Sack,Mary F. Malley,ChiehYing Y. Chang,Saeho Chong,David Wang‐Iverson,Daniel G. Roberts,Steven M. Seiler,William A. Schumacher,Martin L. Ogletree	10
14	Active site-directed synthetic thrombin inhibitors: synthesis, in vitro and in vivo activity profile of BMY 44621 and analogs. An examination of the role of the amino group in the D-Phe-Pro-Arg-H series 1993 ·Journal of Medicinal Chemistry ·Niranjan Balasubramanian,Denis R. St. Laurent,Marianne E. Federici,Nicholas A. Meanwell,John J. Wright,William A. Schumacher,Steven M. Seiler	43
15	Thrombin inhibition compared with other antithrombotic drugs in rats 1992 ·Thrombosis Research ·William A. Schumacher,(unknown),Thomas E. Steinbacher,J R Megill,J. Eileen Bird,Mary R. Giancarli,Stephen K. Durham	10
16	The cardioprotective effects of the thromboxane receptor antagonist SQ 30,741 are not reversed by aspirin 1991 ·Basic Research in Cardiology ·G. J. Grover,Charles S. Parham,William A. Schumacher	15
17	The anaphylatoxins C3a and C5a are vasodilators in the canine coronary vasculaturein vitro andin vivo 1991 ·Inflammation Research ·William A. Schumacher,Joseph C. Fantone,Steve Kunkel,R. Clinton Webb,Benedict R. Lucchesi	56
18	Activity of the short-acting thromboxane receptor antagonist, SQ 30,741, in thrombolytic and vasospastic models in monkeys. 1990 ·Journal of Pharmacology and Experimental Therapeutics ·William A. Schumacher,Christopher L. Heran,Karen S. Hartl,Martin L. Ogletree	5
19	Effect of thromboxane receptor antagonists on renal artery thrombosis in the cynomolgus monkey. 1987 ·Journal of Pharmacology and Experimental Therapeutics ·William A. Schumacher,Harold Goldenberg,Don N. Harris,Martin L. Ogletree	10
20	Effect of the thromboxane synthetase inhibitor UK-37,248 (dazoxiben) upon platelet aggregation, coronary artery thrombosis and vascular reactivity. 1983 ·Journal of Pharmacology and Experimental Therapeutics ·William A. Schumacher,Benedict R. Lucchesi	29

About William A. Schumacher

William A. Schumacher is a scholar working on Internal Medicine, Hematology and Genetics, having authored 82 papers that have together received 2.0k indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (24 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (21 papers) and Antiplatelet Therapy and Cardiovascular Diseases (18 papers). The work is most often cited by research in Hematology (800 citations), Internal Medicine (221 citations) and Genetics (620 citations). William A. Schumacher has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include Martin L. Ogletree, Patricia L. Smith, Thomas E. Steinbacher, Dietmar Seiffert, Benedict R. Lucchesi, Christopher L. Heran, M‐Y. HSU, David Gailani, Xianyu Wang and Gary J. Grover. Their work appears in journals such as Circulation, Blood and Journal of the American College of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact